维普期刊资源整合服务平台（V6.5）

32篇 您的检索式：作者名="Dang CT"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Enhanced endothelial cell apoptosis in splenic tissues of patients with thrombotic thromboytopenic purpura显示文摘	Dang CT Magid MS Weksler B	1999	Blood1999，93，：	1
2	Potential role of selective COX-2 inhibitors in cancer management显示文摘	Dang CT Shapiro CL Hudis CA	2002	Oncology2002，16，：	1
3	Enhanced endothelial cell ap- optosis in splenic tissues of patients with thrombotic thrombocytopenic purpura 显示文摘	Dang CT Magid MS Weksler B	1999	Blood1999，93，4：	1
4	Phase II study of feasibility of dose-dense FEC followed by alternating weekly tax- anes in high-risk, four or more node-positive breast cancer 显示文摘	Dang CT D'Andrea G Moynahan ME	2004	Clin Cancer Res2004，10，：	1
5	Adjuvant paelitaxel and Trastuzumab for node-negative, HER2-positive breast cancer显示文摘	Tolaney SM Barry WT Dang CT	2015	N Engl J Med2015，372，2：	1
6	Adenovirus-mediated combination suicide and cytokine gene therapy for bladder cancer 显示文摘	Freund CT Sutton MA Dang T	2000	Anticancer Res2000，20，3：	1
7	Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer显示文摘	Tolaney SM Barry WT Dang CT	2015	N Engl J Med2015，372，2：	1
8	Enhanced endothelial cell apoptosis in splenic tissues of patients with thrombotic thrombocytopenic purpura显示文摘	Dang CT Magid MS Weksler B	1999	Blood1999，93，4：	1
9	Risk models for neutropenia in patients with breast cancer 显示文摘	Dang CT Fornier MN Hudis CA	2003	Ontology (Williston Park)2003，17，1111：	1
10	Phase Ⅱ study of celecoxib and trastuzumab in metastatic breast cancer patients who have progressed after prior trastuzumabbased trealments 显示文摘	Dang CT Dannenberg AJ Subbaramaiah K	2004	Clin Cancer Res2004，10，121：	1
11	Phase Ⅱ study of feasibility of dose-dense FEC followed by alternating weekly taxanes in high-risk, four or more nodepositive breast cancer 显示文摘	DANG CT D'ANDREA GM MOYNAHAN ME	2004	Clin Cancer Res2004，10，17：	1
12	Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer 显示文摘	Tolaney SM Barry WT Dang CT	2015	N Engl J Med2015，372，2：	1
13	Adjuvant paclitaxel and trastuzumab for node-negative,HER2-positive breast cancer显示文摘	Tolaney SM Barry WT Dang CT	2015	N Engl J Med2015，372，2：	1
14	Adjuvant paclitaxel and trastuzumab for node-negative, HER-2 positive breast cancer 显示文摘	Tolaney SM Barry WT Dang CT	2015	N EnglJ Med2015，372，2：	1
15	Feasibility and cardiac safety of trastuzumab emtansine after anthracycline-based chemotherapy as (neo) adjuvant therapy for human epidermal growth factor receptor 2-positive early-stage breast cancer显示文摘	Krop IE Suter TM Dang CT	2015	J Clin Onco12015，33，10：	1
16	The risk of central nervous system metastases after trastuzumab therapy in patients with breast carcinoma 显示文摘	Lai R Dang CT Malkin MG	2004	Cancer2004，101，4：	1
17	Inhibition of ROS-activated ERK1/2 pathway contributes to the protection of H2S against chemical hypoxia-induced injury in H9c2 cells显示文摘	Dang XB Yang CT Zheng DD	2012	Mol Cell Bio- chem2012，362，12：	1
18	Decitahine rescues cis- pIatin resistance in head and neck squamous cell carcino- ma显示文摘	Viet CT Dang D Achdjian S	2014	PLoS One2014，9，11：	1
19	Enhanced endothelial cell apoptosis in splenic tissues of paeients with thrombotic thrombocytopenic purpura 显示文摘	Dang CT Magid MS Weksler B	1999	Blood1999，93，：	1
20	Enhanced endothelial cell apoptosis in splenic tissues of paeients with thromboric throm-bocytopenic purpura显示文摘	Dang CT Magid MS Weksler B	1999	Blood1999，93，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示